• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    The 11 Steps of Metrology Matching

    Realizing the Promise of Pre-Validated Packaging

    Creating a Natural Extension: Instrument Manufacturing

    Squeaky Clean: Orthopedic Device Packaging & Sterilization

    Natural Selection: Biologics in Orthopedics
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Nevro Files U.S. Patent Lawsuit Against Stimwave

    Global Study Finds High Success Rate for Hip and Knee Replacements

    Life Spine Announces Initiation of SIMPACT Sacroiliac Joint Fixation Outcomes Study

    McGinley Orthopedics Recruits Industry Leader as New CEO

    Study Shows Safety, Efficacy of Radiological Outcomes for Oblique Lateral Lumbar Interbody Fusion
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Nevro Files U.S. Patent Lawsuit Against Stimwave

    Global Study Finds High Success Rate for Hip and Knee Replacements

    McGinley Orthopedics Recruits Industry Leader as New CEO

    Study Shows Safety, Efficacy of Radiological Outcomes for Oblique Lateral Lumbar Interbody Fusion

    Strengthening Muscular Rehabilitation with Objective Clinical Data
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Strengthening Muscular Rehabilitation with Objective Clinical Data

    Nail Simplifies Two-Procedure Rotator Cuff Repair

    Treating that Pain-in-the-Neck Smartphone

    Sounding Board: 2018 Reflections and Looking Ahead

    Creating Customized Orthopedic Products Using Handheld 3D Scanners
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tegra Medical

    Paragon Medical

    Nelson Laboratories LLC

    Atlas Vac Machine

    STAT Design LLC
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Breaking News

    BioArctic Secures Patent for Spinal Cord Injury Treatment

    The product candidate is a combination of a biodegradable medical device and a drug substance (FGF1).

    Related CONTENT
    • Bionik Labs Integrates Amazon Echo into ARKE Exoskeleton
    • Hip Innovation Technology Initiates Clinical Trial of Novel Hip Replacement System
    • Powered Exoskeletons: What Are We Waiting For?
    • Incorporating Payer Requirements into the Development Process
    • 4 FAQs: Medical Device Single Audit Programs
    BioArctic AB02.05.18
    BioArctic AB has been granted a U.S. patent for a method with a medical device to treat patients with complete spinal cord injury.

    The patent protection is in line with the company’s strategy to protect important products through patents. A corresponding patent has previously been granted in China and recently in Australia for product SC0806.
     
    SC0806 is a novel product under development for the treatment for patients with complete spinal cord injury. The product candidate is currently in an ongoing Phase 1/2 clinical trial. The first patient was treated in 2016 at Karolinska University Hospital in Sweden. The product candidate is a combination of a biodegradable medical device and a drug substance (FGF1) designed to support nerve regeneration across the injured area in the spinal cord. The product obtained orphan drug designation in 2010 in the European Union and in 2011 in the United States, which gives the company 10 and seven years of market exclusivity in Europe and the United States, respectively.

    BioArctic's potential regenerative treatment concept consists of a biodegradable device with an adjunctive drug Fibroblast Growth Factor 1 (FGF1) that stiumulates nerve regeneration and reduces scar formation. The project is inlicensed from Swenora Biotech AB and is based on research at Karolinska Institutet and Karolinska University Hospital.

    The treatment includes a surgical procedure in which a degradable implant containing peripheral nerves and growth factor FGF1 are operated into the damaged spinal cord to cause nerve regeneration (overgrowth) of nerve pathways over the area of injury. The device supports the guiding and regeneration of nerves and provides high anatomical precision in the surgical procedure, which aims at functional improvement of significant medical importance. The surgery is then followed by 18 months of rehabilitation.
     
    BioArctic has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No. 643853 to perform a clinical study with SC0806.
     
    A spinal cord injury occurs when trauma or disease damages the spinal cord and results in partial or complete paralysis. The incidence ranges between 12.7 and 44.3 per million inhabitants depending on country.1 Some 40 percent of these patients are estimated to have chronic complete spinal cord injury.2 Patients with complete spinal cord injury require lifelong therapy and care, which means high costs for the healthcare system. The victims are usually young people. The injury has little effect on life expectancy, but leads to major challenges to maintain an acceptable quality of life. Following complete injury, the patient faces a permanent loss of function below the site of injury, with devastating consequences for the patient’s quality of life. Today there is no effective treatment available for the patients.

    BioArctic AB is a Swedish research based biopharmaceutical company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease. The company also develops a potential treatment for complete spinal cord injury. BioArctic focuses on treatments in areas with high unmet medical needs. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and in-house projects with significant market and out-licensing potential. BioArctic’s B-share is listed on Nasdaq Stockholm Mid Cap.

    References
    1. Datamonitor, Stakeholder Opinions: Spinal Cord Injury, 2010.
    2. NSCISC Annual Statistics report 2010.
    Related Searches
    • patent
    • fgf1
    • research
    • diagnostics
    Suggested For You
    In-Human Trials for Stem Cell-Based Cartilage Regeneration Therapy Begin In-Human Trials for Stem Cell-Based Cartilage Regeneration Therapy Begin
    WishBone Medical Names Chief Strategy Officer and Board Member WishBone Medical Names Chief Strategy Officer and Board Member
    Physician, Reinvent Thyself: A Look at Surgeon Inventors Physician, Reinvent Thyself: A Look at Surgeon Inventors
    Outsmarting the Laws of (Mother) Nature Outsmarting the Laws of (Mother) Nature
    An Update on U.S. Obesity and Its Impact on Hip, Knee Transplants An Update on U.S. Obesity and Its Impact on Hip, Knee Transplants
    Virtual Reality Reduces Phantom Pain in Paraplegics Virtual Reality Reduces Phantom Pain in Paraplegics
    Silk Could Be Used to Repair Damaged Spinal Cords Silk Could Be Used to Repair Damaged Spinal Cords
    Mind Over Matter: Brain-Controlled Physical Rehabilitation Mind Over Matter: Brain-Controlled Physical Rehabilitation
    NSF Grant to Fund NSF Grant to Fund 'Bionic Suit' to Help Paraplegics Walk
    First Patients Enrolled in Bioventus First Patients Enrolled in Bioventus' BONES Study for EXOGEN Bone Healing System
    Nanoparticles Limit Damage in Spinal Cord Injury Nanoparticles Limit Damage in Spinal Cord Injury
    Mainstay Medical International Appoints CEO Mainstay Medical International Appoints CEO
    4 FAQs: Medical Device Single Audit Programs 4 FAQs: Medical Device Single Audit Programs
    Incorporating Payer Requirements into the Development Process Incorporating Payer Requirements into the Development Process
    Powered Exoskeletons: What Are We Waiting For? Powered Exoskeletons: What Are We Waiting For?

    Related Breaking News

    • Spine/Neurology
      Nevro Files U.S. Patent Lawsuit Against Stimwave

      Nevro Files U.S. Patent Lawsuit Against Stimwave

      Nevro asserts Stimwave is infringing patent's covering the Senza system and HF10 therapy.
      PR Newswire 02.15.19

    • Large Joint
      Global Study Finds High Success Rate for Hip and Knee Replacements

      Global Study Finds High Success Rate for Hip and Knee Replacements

      Findings showed eight out of ten total knee replacements and six out of ten total hip replacements will still be in place after 25 years.
      University of Bristol 02.15.19

    • Spine/Neurology
      Life Spine Announces Initiation of SIMPACT Sacroiliac Joint Fixation Outcomes Study

      Life Spine Announces Initiation of SIMPACT Sacroiliac Joint Fixation Outcomes Study

      SIMPACT is a cannulated and fenestrated screw, intended for sacroiliac joint fusion.
      Business Wire 02.15.19


    • MIS/Robotics
      McGinley Orthopedics Recruits Industry Leader as New CEO

      McGinley Orthopedics Recruits Industry Leader as New CEO

      Carl O'Connell most recently served as CEO of Xtant Medical.
      PR Newswire 02.14.19

    • Spine/Neurology
      Study Shows Safety, Efficacy of Radiological Outcomes for Oblique Lateral Lumbar Interbody Fusion

      Study Shows Safety, Efficacy of Radiological Outcomes for Oblique Lateral Lumbar Interbody Fusion

      Trial conducted by Inspired Spine.
      PR Newswire 02.14.19

    • Tegra Medical Names New GM

      Tegra Medical Names New GM

      Hal Blenkhorn promoted to general manager of Franklin location.
      Tegra Medical 02.13.19


    • Integra Launches the Panta 2 TTC Arthrodesis Nail System

      Integra Launches the Panta 2 TTC Arthrodesis Nail System

      The product is designed to achieve bone healing through appropriate bone fixation and bone compression.
      Globe Newswire 02.13.19

    • 3-D Printing/Additive Mfg. | Spine/Neurology
      PrinterPrezz & SI Bone Team Up to Advance 3D Printed Orthopedic Tech

      PrinterPrezz & SI Bone Team Up to Advance 3D Printed Orthopedic Tech

      PrinterPrezz will provide SI-BONE with development and build services for potential future 3D-printed advanced medical devices and implants.
      Business Wire 02.12.19

    • Zimmer Biomet Appoints Senior Vice President, Chief Human Resources Officer

      Zimmer Biomet Appoints Senior Vice President, Chief Human Resources Officer

      Company recruited new executive from Pfizer.
      Zimmer Biomet Holdings Inc. 02.12.19


    • Spine/Neurology
      Alphatec Provides Update on NuVasive Patent Lawsuit

      Alphatec Provides Update on NuVasive Patent Lawsuit

      Several favorable developments were announced regarding the company's ongoing patent litigation.
      GlobeNewswire 02.11.19

    • Bracing/Prosthetics
      Motorized Brace to Help Children with Cerebral Palsy

      Motorized Brace to Help Children with Cerebral Palsy

      Research team receives start-up funding to develop first-of-its-kind "artificial muscle."
      University of Delaware 02.11.19

    • Spine/Neurology
      FDA Approves Orthofix

      FDA Approves Orthofix's M6-C Artificial Cervical Disc for Cervical Disc Degeneration Treatment

      The disc was developed by Spinal Kinetics, a company Orthofix acquired last spring.
      Business Wire 02.11.19

    • American Academy of Orthopaedic Surgeons Announces its Musculoskeletal Tumor Registry Pilot

      American Academy of Orthopaedic Surgeons Announces its Musculoskeletal Tumor Registry Pilot

      Year-long effort includes six pilot sites at major U.S. academic center.
      American Academy of Orthopaedic Surgeons 02.08.19

    •  Trice Medical Acquires SegWAY Orthopaedics

      Trice Medical Acquires SegWAY Orthopaedics

      Acquisition creates first company to offer product line for minimally invasive orthopedic diagnostics and surgical solutions.
      Business Wire 02.07.19

    • Gramercy Extremity Orthopedics Receives Patent for Variable Angle Locking Technology

      Gramercy Extremity Orthopedics Receives Patent for Variable Angle Locking Technology

      The patent covers a design that allows a screw to be fixed at various angles and orientations using self-aligning washers within the plate hole.
      EINPresswire.com 02.07.19


    Breaking News
    • Nevro Files U.S. Patent Lawsuit Against Stimwave
    • Global Study Finds High Success Rate for Hip and Knee Replacements
    • Life Spine Announces Initiation of SIMPACT Sacroiliac Joint Fixation Outcomes Study
    • McGinley Orthopedics Recruits Industry Leader as New CEO
    • Study Shows Safety, Efficacy of Radiological Outcomes for Oblique Lateral Lumbar Interbody Fusion
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • The 11 Steps of Metrology Matching
    • Realizing the Promise of Pre-Validated Packaging
    • Creating a Natural Extension: Instrument Manufacturing
    • Squeaky Clean: Orthopedic Device Packaging & Sterilization
    • Natural Selection: Biologics in Orthopedics
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login